225 related articles for article (PubMed ID: 30638177)
21. β-Lapachone enhances Mre11-Rad50-Nbs1 complex expression in cisplatin-induced nephrotoxicity.
Kim TW; Kim YJ; Kim HT; Park SR; Jung JY
Pharmacol Rep; 2016 Feb; 68(1):27-31. PubMed ID: 26721347
[TBL] [Abstract][Full Text] [Related]
22. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis.
Taylor AM; Groom A; Byrd PJ
DNA Repair (Amst); 2004; 3(8-9):1219-25. PubMed ID: 15279810
[TBL] [Abstract][Full Text] [Related]
23. ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance.
Millour J; de Olano N; Horimoto Y; Monteiro LJ; Langer JK; Aligue R; Hajji N; Lam EW
Mol Cancer Ther; 2011 Jun; 10(6):1046-58. PubMed ID: 21518729
[TBL] [Abstract][Full Text] [Related]
24. High Expression of MRE11-RAD50-NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer.
Altan B; Yokobori T; Ide M; Bai T; Yanoma T; Kimura A; Kogure N; Suzuki M; Bao P; Mochiki E; Ogata K; Handa T; Kaira K; Nishiyama M; Asao T; Oyama T; Kuwano H
Anticancer Res; 2016 Oct; 36(10):5237-5247. PubMed ID: 27798884
[TBL] [Abstract][Full Text] [Related]
25. Intracellular redistribution and modification of proteins of the Mre11/Rad50/Nbs1 DNA repair complex following irradiation and heat-shock.
Seno JD; Dynlacht JR
J Cell Physiol; 2004 May; 199(2):157-70. PubMed ID: 15039997
[TBL] [Abstract][Full Text] [Related]
26. Molecular disruption of RAD50 sensitizes human tumor cells to cisplatin-based chemotherapy.
Abuzeid WM; Jiang X; Shi G; Wang H; Paulson D; Araki K; Jungreis D; Carney J; O'Malley BW; Li D
J Clin Invest; 2009 Jul; 119(7):1974-85. PubMed ID: 19487811
[TBL] [Abstract][Full Text] [Related]
27. Impairment of double-strand breaks repair and aberrant splicing of ATM and MRE11 in leukemia-lymphoma cell lines with microsatellite instability.
Ham MF; Takakuwa T; Luo WJ; Liu A; Horii A; Aozasa K
Cancer Sci; 2006 Mar; 97(3):226-34. PubMed ID: 16542220
[TBL] [Abstract][Full Text] [Related]
28. Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation.
Aimjongjun S; Mahmud Z; Jiramongkol Y; Alasiri G; Yao S; Yagüe E; Janvilisri T; Lam EW
BMC Cancer; 2019 Nov; 19(1):1106. PubMed ID: 31727006
[TBL] [Abstract][Full Text] [Related]
29. The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells.
Hou Y; Zhu Q; Li Z; Peng Y; Yu X; Yuan B; Liu Y; Liu Y; Yin L; Peng Y; Jiang Z; Li J; Xie B; Duan Y; Tan G; Gulina K; Gong Z; Sun L; Fan X; Li X
Cell Death Dis; 2017 Mar; 8(3):e2659. PubMed ID: 28277541
[TBL] [Abstract][Full Text] [Related]
30. ATM activation is impaired in human cells defective in RecQL4 helicase activity.
Park SY; Kim H; Im JS; Lee JK
Biochem Biophys Res Commun; 2019 Feb; 509(2):379-383. PubMed ID: 30594395
[TBL] [Abstract][Full Text] [Related]
31. Two-step activation of ATM by DNA and the Mre11-Rad50-Nbs1 complex.
Dupré A; Boyer-Chatenet L; Gautier J
Nat Struct Mol Biol; 2006 May; 13(5):451-7. PubMed ID: 16622404
[TBL] [Abstract][Full Text] [Related]
32. ATM-Dependent Phosphorylation of All Three Members of the MRN Complex: From Sensor to Adaptor.
Lavin MF; Kozlov S; Gatei M; Kijas AW
Biomolecules; 2015 Oct; 5(4):2877-902. PubMed ID: 26512707
[TBL] [Abstract][Full Text] [Related]
33. Distinct functions of Nijmegen breakage syndrome in ataxia telangiectasia mutated-dependent responses to DNA damage.
Lee JH; Xu B; Lee CH; Ahn JY; Song MS; Lee H; Canman CE; Lee JS; Kastan MB; Lim DS
Mol Cancer Res; 2003 Jul; 1(9):674-81. PubMed ID: 12861053
[TBL] [Abstract][Full Text] [Related]
34. Lack of MRE11-RAD50-NBS1 (MRN) complex detection occurs frequently in low-grade epithelial ovarian cancer.
Brandt S; Samartzis EP; Zimmermann AK; Fink D; Moch H; Noske A; Dedes KJ
BMC Cancer; 2017 Jan; 17(1):44. PubMed ID: 28073364
[TBL] [Abstract][Full Text] [Related]
35. SMAD3 silencing enhances DNA damage in radiation therapy by interacting with MRE11-RAD50-NBS1 complex in glioma.
Jiang Z; Guo Y; Miao L; Han L; Zhang W; Jiang Y
J Biochem; 2019 Apr; 165(4):317-322. PubMed ID: 30535026
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of cisplatin on nasopharyngeal carcinoma cells may be increased via the downregulation of fibroblast growth factor receptor 2.
Pu L; Su L; Kang X
Int J Mol Med; 2019 Jul; 44(1):57-66. PubMed ID: 31115494
[TBL] [Abstract][Full Text] [Related]
37. ATM activation by oxidative stress.
Guo Z; Kozlov S; Lavin MF; Person MD; Paull TT
Science; 2010 Oct; 330(6003):517-21. PubMed ID: 20966255
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of FOXM1 is associated with metastases of nasopharyngeal carcinoma.
Jiang L; Wang P; Chen H
Ups J Med Sci; 2014 Nov; 119(4):324-32. PubMed ID: 25231007
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis.
Ho V; Chung L; Singh A; Lea V; Abubakar A; Lim SH; Ng W; Lee M; de Souza P; Shin JS; Lee CS
BMC Cancer; 2018 Sep; 18(1):869. PubMed ID: 30176843
[TBL] [Abstract][Full Text] [Related]
40. FOXM1 confers acquired cisplatin resistance in breast cancer cells.
Kwok JM; Peck B; Monteiro LJ; Schwenen HD; Millour J; Coombes RC; Myatt SS; Lam EW
Mol Cancer Res; 2010 Jan; 8(1):24-34. PubMed ID: 20068070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
